← Back to Search

Patient-Reported Data Tracking for Cancer

N/A
Recruiting
Led By Katie Reeder-Hayes
Research Sponsored by UNC Lineberger Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have not yet initiated cancer treatment on the date of enrollment
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 180 days post-enrollment
Awards & highlights

Study Summary

This trial aims to identify cancer patients at risk of delayed treatment, so interventions can be provided to get them treatment faster. 240 colorectal and breast cancer patients will be studied.

Who is the study for?
This trial is for adults over 18 with a recent diagnosis of breast or colorectal cancer who plan to receive treatment at the University of North Carolina. They must be able to get and respond to surveys electronically and give consent. Those without email or smartphone access, unable to consent, or not fluent in English cannot join.Check my eligibility
What is being tested?
The study tests an electronic tool where patients report issues that might delay their cancer treatment. It aims to identify if there's a link between race, social factors, and treatment delays using patient feedback and health records.See study design
What are the potential side effects?
Since this trial involves completing weekly surveys rather than testing medications, there are no direct medical side effects associated with participating in this research.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have not started any cancer treatment yet.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 180 days post-enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 180 days post-enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Electronic patient-reported outcome (ePRO) confirming treatment initiation
Feasibility of Electronic patient-reported outcome (ePRO)
Secondary outcome measures
Delayed Treatment
Proportion of treatment delay
Time to ePRO-reported treatment
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: electronic patient-reported outcome (ePRO) questionnaires.Experimental Treatment1 Intervention
Subjects with colon or breast carcinoma will respond to weekly electronic patient-reported outcome (ePRO) questionnaires.

Find a Location

Who is running the clinical trial?

UNC Lineberger Comprehensive Cancer CenterLead Sponsor
353 Previous Clinical Trials
90,173 Total Patients Enrolled
51 Trials studying Breast Cancer
27,746 Patients Enrolled for Breast Cancer
Katie Reeder-HayesPrincipal InvestigatorUNC Lineberger Comprehensive Cancer Center
~160 spots leftby May 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top